Events

Upcoming events

   

 JP Morgan Healthcare Conference

San Francisco, CA, 7-10 January 2019

Silence Therapeutics management team will be in San Francisco

 

Past events

 

American Society of Hematology (ASH) Annual Meeting 2018

San Diego, CA, 29 November – 4 December 2018

Ute Schaeper, Discovery Research Project Leader, will be presenting

 

Haemochromatosis UK reception at The House of Commons

London, UK, 31 October 2018

David Horn Solomon, CEO, will attend

 

European Nephrology Conference

Warsaw, 15-16 October 2018

Steffen Schubert, Head of Pre-clinical Drug Discovery, attended

 

Cantor Fitzgerald 2018 Global Healthcare Conference

New York, NY, 3 October 2018

David Horn Solomon, CEO, presented 

The webcast may be accessed by clicking here

  

The Oligo Meeting 2018

Seattle, WA, 1-3 October 2018

Adrien Weingaertner, Group Leader - Drug Delivery, presented 

  

Half Year Results 2018

London, UK, 11 September 2018

Investor call hosted by David Horn Solomon, CEO, and David Ellam, CFO

Listen to the recording here 

 

RNA Therapeutics: From Base Pairs to Bedside

Worcester, Umass, 28-29 June 2018

Marie Lindholm, Head of Technology Innovation, presented

 

European Hematology Association (EHA)

Stockholm, Sweden, 14-17 June 2018

Ute Schaeper, Discovery Research Project Leader, presented

 

2018 Bio International Convention

Boston, MA, 4-7 June 2018

 

US-Tides

Boston, MA, 7-10 May 2018

Torsten Hoffmann, CSO, presented

 

9th Clinical Trials Innovation Programme

Frankfurt, Germany, 26-27 April 2018

Torsten Hoffmann, CSO, presented

 

Oligo 2018

Oxford, UK, 10 April 2018

Adrien Weingaertner, Group Leader, Drug Delivery, presented

 

Rare Disease Symposium at OPT Congress

Boston, MA, 28 March 2018

Torsten Hoffmann, COO, presented and appeared as a panelist

 

Oligonucleotide & Peptide Therapeutics (OPT)

Boston, MA, 26-28 March 2018

Marie Lindholm, Head of Technology Innovation, presented

 

Cowen 38th Annual Health Care Conference

Boston, MA, 12-14 March 2018

Click here to register in advance for the live webcast.   A replay of the webcast will be available for 14 business days through the same link 

Presentation by Ali Mortazavi, CEO

 

Full Year Results 2017

London, UK, 6 March 2018

 

AsiaTIDES  

Kyoto, Japan, 27 February - 1 March 2018

Presentation by Torsten Hoffmann, COO

Afternoon session chaired by Torsten Hoffmann, COO

 

JP Morgan Healthcare Conference

San Francisco CA, 8-11 January 2018

 

14th International Conference on Thalassaemia & Haemoglobinopathies

Thessaloniki, Greece, 17-19 November 2017

 

Capital Markets Day

London, UK, 14 November 2017

 

5th Canton Nucleic Acids Forum (CNAF)

Guangzhou, China, 9-10 November 2017

 

17th Annual Biotech in Europe Forum

Basel, Switzerland, 26-27 September 2017

 

Canaccord Genuity 37th Annual Growth

Boston MA, 9-10 August 2017

 

TIDES: Oligonucleotide and peptide therapeutics

San Diego CA, 30 April – 3 May 2017

 

OLIGO 2017 OXFORD

Antisense & Therapeutic Nucleic Acids

Oxford, UK, 10 April 2017

 

Oligonucleotide and Peptide Therapeutics

Boston MA, 26-29 March 2017

 

‘Therapeutic RNA delivery: into hepatocytes and beyond’

AsiaTIDES

Kyoto, Japan, 21-23 February 2017

 

'Hepatic gene disruption in vivo after liposomal delivery of Cas9 mRNA and chemically modified guide RNAs’

EuroTides

Berlin, Germany, 14-16 November 2016